You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 107 No. 8, August 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  LABORATORY SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Spontaneous Canine Keratoconjunctivitis Sicca

A Useful Model for Human Keratoconjunctivitis Sicca: Treatment With Cyclosporine Eye Drops

Renee L. Kaswan, DVM, MS; Mary-Alice Salisbury, DVM; Daniel A. Ward, DVM

Arch Ophthalmol. 1989;107(8):1210-1216.


Abstract

• Thirty-six sequential cases of canine keratoconjunctivitis sicca (KCS) were treated with ophthalmic cyclosporine. The effects of topical cyclosporine were twofold: (1) cyclosporine increased tear production by 5 mm/min or greater in all cases of spontaneous KCS having an initial Schirmer's Tear Test value greater than 2 mm /min and in 59% of eyes with an initial Schirmer's Tear Test value of 0 to 2 mm/min, and (2) cyclosporine caused marked regression of chronic corneal neovascularization and granulation even in eyes in which lacrimation failed to improve. Additional benefits of topical cyclosporine were reduced mucopurulent conjunctivitis, rapid healing of nonhealing corneal ulcers, and reduced dependence on frequent topical treatments of KCS. Twelve normal beagles treated with topical cyclosporine also had a reversible increase in lacrimation compared with baseline or placebo control-treated dogs.



Author Affiliations

From the Department of Small Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens.


Footnotes

Accepted for publication January 24,1989.

Reprint requests to the College of Veterinary Medicine, University of Georgia, Athens, GA 30602 (Dr Kaswan).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Neurologic Evaluation of Acute Lacrimomimetic Effect of Cyclosporine in an Experimental Rabbit Dry Eye Model
Toshida et al.
IOVS 2009;50:2736-2741.
ABSTRACT | FULL TEXT  

Protective Effect of D-{beta}-Hydroxybutyrate on Corneal Epithelia in Dry Eye Conditions through Suppression of Apoptosis
Nakamura et al.
IOVS 2003;44:4682-4688.
ABSTRACT | FULL TEXT  

A Mouse Model of Keratoconjunctivitis Sicca
Dursun et al.
IOVS 2002;43:632-638.
ABSTRACT | FULL TEXT  

Effect of Cyclosporine on Conjunctival Mucin in a Canine Keratoconjunctivitis Sicca Model
Moore et al.
IOVS 2001;42:653-659.
ABSTRACT | FULL TEXT  

Improvement of Lacrimal Function by Topical Application of CyA in Murine Models of Sjogren's Syndrome
Tsubota et al.
IOVS 2001;42:101-110.
ABSTRACT | FULL TEXT  

Analysis of Topical Cyclosporine Treatment of Patients With Dry Eye Syndrome: Effect on Conjunctival Lymphocytes
Kunert et al.
Arch Ophthalmol 2000;118:1489-1496.
ABSTRACT | FULL TEXT  

Suppression of Corneal Neovascularization With Cyclosporine
Lipman et al.
Arch Ophthalmol 1992;110:405-407.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.